Nils Loewen, M.D.

Topics will include:

• Evidence
• Technique
• Economic

VIEW RECORDING

L. Jay Katz, M.D..

Robert Noecker,
MD, MBA

Topics will include:

• Comparison of Efficacy of Selective Laser Trabeculoplasty versus Medication as Initial Glaucoma therapy
• Review of SLT and medication treatment algorithms used in the study
• Evaluation of secondary factors including compliance, cost and patient preference
• Assessment of need for additional interventions in both therapy arms
• Conclusions

VIEW RECORDING

Brian Francis, M.D.

L. Jay Katz, M.D.

Topics will include:

• Study parameters of SLT2
• Patient Selection
• Clinical outcomes; A Multi-Center Study Findings
• What does this mean for compliance?
• Impact on your practice
• And more!
  

VIEW RECORDING

David A Goldman, M.D

Topics will include:

• Ocular Surface Disease
• Improving Patient Outcomes
• Therapeutic Benefits of SLT
• Financial Benefits of SLT

VIEW RECORDING 

Donald Budenz MD

Steven Gedde MD

VIEW RECORDING

Anthony D. Realini M.D.

Topics will include:

• Use of SLT to manage the medically non-adherent patient
• Ophthalmologists role in managing the underinsured and uninsured glaucoma patient in the United States
• Role of SLT in managing glaucoma in the developing world

VIEW RECORDING

Donald Budenz, M.D.

Topics will include:

• SLT as First line Therapy in managing Open-Angle Glaucoma
  
• SLT as Adjunct to or Replacement of Medical Therapy
  
• Review of Clinical Cases
  
• Repeatability of SLT beyond previously treated (360 degrees)
  patients
  

VIEW RECORDING  

Richard A. Quinones, M.D.

Topics will include:

• Safe: SLT is not associated with systemic side effects, collateral tissue damage or the compliance and cost issues of medications
  
• Selective: SLT utilizes selective photothermolysis in order to target melanin-containing TM cells while leaving the surrounding tissue intact and without thermal damage
  
• Smart: SLT stimulates the body's natural mechanisms to enhance outflow of the aqueous humor and consequently – reduction in IOP level
  
• Sensible: SLT therapy is reimbursed by Medicare and many other insurance providers, minimizing your patient's out-of pocket
  
  

VIEW RECORDING

Mark A. Latina, M.D.

Topics will include:

• Safe: SLT is not associated with systemic side effects, collateral tissue damage or the compliance and cost issues of medications
  
• Selective: SLT utilizes selective photothermolysis in order to target melanin-containing TM cells while leaving the surrounding tissue intact and without thermal damage
  
• Smart: SLT stimulates the body's natural mechanisms to enhance outflow of the aqueous humor and consequently – reduction in IOP level
  
• Sensible: SLT therapy is reimbursed by Medicare and many other insurance providers, minimizing your patient's out-of pocket
  
  

VIEW RECORDING

Jason Bacharach, M.D.

Topics will include:

• Safe: SLT is not associated with systemic side effects, collateral tissue damage or the compliance and cost issues of medications
  
• Selective: SLT utilizes selective photothermolysis in order to target melanin-containing TM cells while leaving the surrounding tissue intact and without thermal damage
  
• Smart: SLT stimulates the body's natural mechanisms to enhance outflow of the aqueous humor and consequently – reduction in IOP level
  
• Sensible: SLT therapy is reimbursed by Medicare and many other insurance providers, minimizing your patient's out-of pocket
  
  

VIEW RECORDING

L. Jay Katz, M.D.

Jorge A. Alvarado, M.D.

Topics will include:

• Pro Medications: Background, Rationale and Advocacy for hypotensive medications as 1st Line Therapy. L.J. Katz MD Wills Eye Hospital
  
• Pro Laser Trabeculoplasty (SLT): Foundation, underlying principles and support of SLT as a viable 1st Line Therapy. Jorge A. Alvarado MD UC San Francisco
  
• Rebuttal and Closing Arguments
  
• How to use SLT and Medications synergistically in order to maximize benefits and minimize limitations of their use as combination therapy to manage open-angle glaucoma
  
  

VIEW RECORDING

Brian Francis, M.D.

Topics will include:

• Appropriate Patient Selection prior to SLT therapy
  
• When should SLT be used as 1st Line Therapy to manage POAG?
  
• Repeating SLT laser therapy after successful (>360°)
  
• How to effectively reduce anti-glaucoma medications with SLT therapy
• Versatility of SLT therapy in Clinical practice
  
  

VIEW RECORDING

E. Randy Craven, M.D.

Topics will include:

• Why offer SLT
  
• Benefits of Performing SLT in the Surgery Center
  
• Throughput & Efficiency Gained by the Duet
  
• Financial Analysis for Varying Ownership Levels
  
  

VIEW RECORDING

Richard A. Quinones, M.D.

Topics will include:

• The value of SLT in a private practice setting
  
• SLT as primary or adjunctive therapy
  
• Reducing or replacing glaucoma medications
  
• The benefits of combining SLT with mono-therapy
  
• Detecting non-adherence with glaucoma therapy
• Helping patients cope with the high cost of medications
  

VIEW RECORDING

Ronald Salvitti, M.D.

Jennifer Davis, M.D.

Topics will include:

• Why offer SLT?
  
• Benefits of Performing SLT in the Surgery Center
  
• Throughput & Efficiency Gained by the Duet
  
• Patient Compliance
  
• Patient Education & Marketing
  

VIEW RECORDING

Mildred M.G. Olivier , M.D.

Topics will include:

• Glaucoma Management Paradigm
  
• Need for Access to Medical Therapy
  
• Why Offer SLT to Underserved
  
• Benefits to Patients and Health Care System
  
• Clinical Case Studies
  

VIEW RECORDING

Robert Weinreb, M.D.

Earlier Detection. Earlier Treatment. Better Outcomes!

VIEW RECORDING

Mark Latina, M.D.

Earlier Treatment. Better Outcomes!

VIEW RECORDING

David Huang, M.D.

Advancement in the Science and Understanding of Glaucoma

VIEW RECORDING

Earlier Detection. Earlier Treatment. Better Outcomes!

VIEW RECORDING

Brian Francis , M.D.

Topics will include:

• Repeat SLT laser trabeculoplasty (>360°)
  
• Retreating previously treated SLT patients
  
• Reducing and or replacing of anti-glaucoma
  medications with SLT therapy
• Successful SLT therapy in patients after
  previous trabeculectomy
• Integrating SLT into clinical practice
  
• Update on SLT clinical studies

VIEW RECORDING

L. Jay Katz, M.D.

Topics will include:

• Goals of Glaucoma therapy
• SLT a viable 1st Line Therapy
• SLT vs. Medications
• Safety, Compliance and Cost:
  • Medications, Laser & Filtration Surgeries
  • Repeat SLT Therapy

VIEW RECORDING

Jorge A. Alvarado, MD

Topics will include:

• Fundamentals of SLT
• Review of latest SLT studies that promote better quality of life and cost savings for POAG patients
• Review of clinical applications
• Integrating SLT into your clinical practice
• Financial considerations regarding this therapy

VIEW RECORDING

Robert Noecker,
MD, MBA

Topics will include:

• The underlying mechanisms of SLT
• Patient Selection and SLT
• SLT as Primary, Secondary or Adjunct Therapy
• Integrating SLT into your clinical practice
• SLT and its evolving role in the management
  of Glaucoma
• Learn more about SLT for the Treatment of Glaucoma

VIEW RECORDING

Jorge A. Alvarado, MD

Topics will include:

• The underlying mechanisms of SLT
• Patient Selection and SLT
• SLT as Primary, Secondary or Adjunct Therapy
• Integrating SLT into your clinical practice
• SLT and its evolving role in the management of Glaucoma

VIEW RECORDING
(audio only)

Topics will include:

• Fundamentals of SLT
• Clinic Results of Primary and Repeat Treatment
• Practical usage of SLT in your office

VIEW RECORDING  

Lawrence Morse, MD, PhD

Topics will include:

• Fundamentals of Retinal lasers
• Main Clinical applications of photocoagulators
• Recent trends in Retinal photocoagulation
• Current Role of Thermal lasers in treating:
  • Diabetic Retinopathy and
  • Age-related Macular Degeneration
• Photocoagulation usage in Retina casesan
  Anti-VEGF world
• Advantages of solid-state,
• Multi-wavelength Lasers
• Review of Clinical Casesment

VIEW RECORDING